help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galve-de Rochemonteix, B.
Right arrow Articles by Dayer, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galve-de Rochemonteix, B.
Right arrow Articles by Dayer, J. M.

Am. J. Respir. Cell Mol. Biol., Vol 14, No. 3, 03 1996, 279-287.

Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma

B Galve-de Rochemonteix, LP Nicod and JM Dayer
Division of Immunology and Allergy, Hans Wilsdorf Laboratory, Geneva, Switzerland.

Tumor necrosis factor alpha(TNF alpha), a proinflammatory cytokine secreted predominantly by monocytemacrophages, interacts with two cell- surface receptors: TNF-R55 and TNF-R75. Few studies have been devoted to their modulation on human alveolar macrophages (AM). Both source and target of TNF(alpha), AM also release its inhibitors, the soluble receptors, following the cleavage of the extracellular domain of TNF- R55 and TNF-R75. Because in vivo AM are subject to activation by exogenous or endogenous stimuli, we analyzed the release of both receptors into the cell culture supernatant in response to lipopolysaccharide (LPS), phorbol myristate acetate (PMA), and cytokines such as interleukin 2(IL-2), IL-4, IL-6, granulocyte- macrophage colony-stimulating factor (GM-CSF), and interferon gamma (IFN-gamma). Results were compared with those obtained on peripheral blood monocytes (Mo), and the role of receptor recycling was investigated using inhibitors such as monensin and chloroquine. In our culture conditions, basal release by unstimulated AM amounted to 0.3 +/- 0.1 and 0.5 +/- 0.1 ng/ml for TNF-sR55 and TNF-sR75, respectively. In the same conditions, Mo released 1.2 +/- 1.2 ng/ml of TNF-sR55 and 5.1 +/- 0.1 ng/ml of TNF-sR75. PMA slightly increased mRNA expression and release of TNF-sR55, but those of TNF-sR75 were enhanced approximately 4-fold. After 24 h of culture, the release of TNF-sR75 was 2.5-fold higher on Mo than on AM. Of the cytokines tested on AM, IFN-gamma increased the release of TNF-sR75 3-fold, but that of TNF-sR55 only between 1.5- and 2-fold. GM-CSF enhanced them to a lower extent (approximately 1.5-fold). Shedding occurred despite the presence of chloroquine, monensin and colchicine, suggesting that cleavage takes place on the cell surface rather than after internalization. Addition of colchicine increased the release of TNF-sR75 induced by LPS and IFN- gamma, but not by PMA. In conclusion, Mo and AM differ in their ability to release TNF(alpha) and TNF-sR. On AM the release of each receptor appears to be regulated separately. Finally, IFN-gamma was among the most efficacious cytokines to induce the release of both receptors, with TNF-sR75 being more liable to shedding. Thus, the two TNF-R seem to be ruled by separate mechanisms and to differ in terms of release sensitivity.


This article has been cited by other articles:


Home page
ERRHome page
L. P. Nicod
Lung defences: an overview
Eur. Respir. Rev., December 1, 2005; 14(95): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Pedron, R. Girard, and R. Chaby
TLR4-dependent Lipopolysaccharide-induced Shedding of Tumor Necrosis Factor Receptors in Mouse Bone Marrow Granulocytes
J. Biol. Chem., May 30, 2003; 278(23): 20555 - 20564.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Gumenscheimer, I. Mitov, C. Galanos, and M. A. Freudenberg
Beneficial or Deleterious Effects of a Preexisting Hypersensitivity to Bacterial Components on the Course and Outcome of Infection
Infect. Immun., October 1, 2002; 70(10): 5596 - 5603.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C.P. Coyne, T. Howell, H. Smodlaka, C. Willetto, B. W. Fenwick, and E. Chenney
Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease
Innate Immunity, August 1, 2002; 8(4): 273 - 283.
[Abstract] [PDF]


Home page
ThoraxHome page
M J Plummeridge, L Armstrong, M A Birchall, and A B Millar
Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects
Thorax, October 1, 2000; 55(10): 842 - 847.
[Abstract] [Full Text]


Home page
ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]


Home page
ThoraxHome page
L. Armstrong, N. M Foley, and A. B Millar
Inter-relationship between tumour necrosis factor-alpha (TNF-alpha ) and TNF soluble receptors in pulmonary sarcoidosis
Thorax, June 1, 1999; 54(6): 524 - 530.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Balcewicz-Sablinska, J. Keane, H. Kornfeld, and H. G. Remold
Pathogenic Mycobacterium tuberculosis Evades Apoptosis of Host Macrophages by Release of TNF-R2, Resulting in Inactivation of TNF-{alpha}
J. Immunol., September 1, 1998; 161(5): 2636 - 2641.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Tinkle and L. Newman
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease
Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1884 - 1891.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. VISCARDI, J. D. HASDAY, K. F. GUMPPER, V. TACIAK, A. B. CAMPBELL, and T. W. PALMER
Cromolyn Sodium Prophylaxis Inhibits Pulmonary Proinflammatory Cytokines in Infants at High Risk for Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1523 - 1529.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. P. Nicod and P. Isler
Alveolar Macrophages in Sarcoidosis Coexpress High Levels of CD86 (B7.2), CD40, and CD30L
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 91 - 96.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1996 American Thoracic Society.